A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get notified once we do.
Myleran (busulfan) is an alkylating agent used for the palliative treatment of chronic myelogenous leukemia.
Myleran (busulfan) is available in a scored 2 mg oral tablet.
Adult Myleran dosage for remission induction: 4 mg to 8 mg by mouth daily.
Each Myleran tablet contains the active ingredient, Busulfan.
Do not take Myleran if you have not been definitively diagnosed with chronic myelogenous leukemia.
Do not take Myleran if you are allergic to busulfan or any of the other ingredients. Discuss your allergies with your doctor.
MYLERAN is a potent drug. It should not be used unless a diagnosis of chronic myelogenous leukemia has been adequately established and the responsible physician is knowledgeable in assessing response to chemotherapy.
MYLERAN can induce severe bone marrow hypoplasia. Reduce or discontinue the dosage immediately at the first sign of any unusual depression of bone marrow function as reflected by an abnormal decrease in any of the formed elements of the blood. A bone marrow examination should be performed if the bone marrow status is uncertain.
SEE WARNINGS FOR INFORMATION REGARDING BUSULFAN-INDUCED LEUKEMOGENESIS IN HUMANS.
Tell your doctor about all the medications you take, including over-the-counter medications, vitamins, and supplements. Myerlan can interact with certain medications that can lead to unpleasant or dangerous reactions.
Once you are prescribed and buy Myleran, it is important to know that Myleran may induce bone marrow failure which can lead to low blood cell counts. Exercise extreme caution if your bone marrow reserve has been affected.
The use of Myleran can cause bronchopulmonary dysplasia with pulmonary fibrosis. Seek medical care immediately if you experience a cough, shortness of breath, and a fever.
Myleran can cause cellular dysplasia in many organs, including the lungs.
Malignant tumors and acute leukemias have been observed in patients who took Myleran.
Suppression of the ovaries and the absence of menstruation with symptoms of menopause have been experienced in premenopasual patients who have received Myleran.
Male patients may experience sterility, testicular atrophy, and the absence of sperm with Myleran therapy.
Hepatic veno-occlusive disease may occur with the use of Myleran, especially if taken with cyclophosphamide or other chemotherapeutic agents before bone marrow transplantation. Liver enzymes should be monitored.
Cardiac tamponade has been seen in patients with thalassemia who have received Myleran and cyclophosphamide.
Tell your doctor if you are pregnant or plan to become pregnant. Myleran may cause harm to an unborn fetus.
Tell your doctor if you are breastfeeding or plan to breastfeed.
Side effects may occur with the use of Myleran, and some side effects can be severe. Myleran may cause:
Tell your doctor right away if you experience side effects that are bothersome or won't go away.
With a valid prescription, you can buy Myleran (busulfan) 2 mg tablets at a competitive price online at Canada Pharmacy.